Management of postblepharoplasty chemosis

Aesthet Surg J. 2013 Jul;33(5):654-61. doi: 10.1177/1090820X13487016. Epub 2013 Jun 6.

Abstract

Clinically significant chemosis occasionally complicates lower eyelid blepharoplasty. In this report, the etiologic components of postblepharoplasty chemosis are discussed. The time course and duration of chemosis vary according to the underlying cause. Early, late, and prolonged chemosis are managed with different strategies. Diagnostic and therapeutic algorithms for chemosis assessment and management are presented.

Keywords: blepharoplasty; chemosis; complication; conjunctiva.

MeSH terms

  • Aged
  • Algorithms*
  • Anti-Inflammatory Agents / therapeutic use
  • Blepharoplasty / adverse effects*
  • Blepharoplasty / methods
  • Combined Modality Therapy
  • Conjunctival Diseases / etiology*
  • Conjunctival Diseases / physiopathology
  • Conjunctival Diseases / therapy*
  • Cortisone / therapeutic use
  • Drug Therapy, Combination
  • Edema / etiology
  • Edema / therapy*
  • Eyelids / surgery*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Postoperative Complications / diagnosis
  • Postoperative Complications / therapy
  • Reoperation
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Cortisone